The role of CXC chemokines and their receptors in cancer

被引:542
作者
Vandercappellen, Jo [1 ]
Van Damme, Jo [1 ]
Struyf, Sofie [1 ]
机构
[1] Univ Louvain, Rega Inst Med Res, Lab Mol Immunol, B-3000 Louvain, Belgium
关键词
angiogenesis; cancer; chemokines; GPCR; metastasis; tumorigenesis;
D O I
10.1016/j.canlet.2008.04.050
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chemokines. or chemotactic cytokines. and their receptors have been discovered as essential and selective mediators in leukocyte migration to inflammatory sites and to secondary lymphoid organs. Besides their functions in the immune system, they also play a critical role in tumor initiation. promotion and progression. There are four subgroups of chemokines: CXC, CC, CX3C. and C chemokine ligands. The CXC or alpha subgroup is further subdivided in the ELR+ and ELR chemokines. Members that contain the ELR motif hind to CXC chemokine receptor 2 (CXCR2) and are angiogenic. In contrast, most of the CXC chemokines without ELR motif bind to CXCR3 and are angiostatic. Ail exception is the angiogenic ELR-CXC chemokine stromal cell-derived factor-1 (CXCL12/SDF-1). which binds to CXCR4 and CXCR7 and is implicated in tumour metastasis. This review is focusing oil the role of CXC chemokines and their receptors in tumorigenesis, including angiogenesis. attraction of leukocytes to tumour sites and induction of tumour Cell migration and homing in metastatic sites. Finally, their therapeutic Use In Cancer treatment is discussed. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:226 / 244
页数:19
相关论文
共 193 条
  • [1] The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity
    Addison, CL
    Daniel, TO
    Burdick, MD
    Liu, H
    Ehlert, JE
    Xue, YY
    Buechi, L
    Walz, A
    Richmond, A
    Strieter, RM
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (09) : 5269 - 5277
  • [2] Overexpression of the duffy antigen receptor for chemokines (DARC) by NSCLC tumor cells results in increased tumor necrosis
    Addison, CL
    Belperio, JA
    Burdick, MD
    Strieter, RM
    [J]. BMC CANCER, 2004, 4 (1)
  • [3] The CXC chemokine, monokine induced by interferon-γ, inhibits non-small cell lung carcinoma tumor growth and metastasis
    Addison, CL
    Arenberg, DA
    Morris, SB
    Xue, YY
    Burdick, MD
    Mulligan, MS
    Iannettoni, MD
    Strieter, RM
    [J]. HUMAN GENE THERAPY, 2000, 11 (02) : 247 - 261
  • [4] CXCR5 may be involved in the attraction of human metastatic neuroblastoma cells to the bone marrow
    Airoldi, Irma
    Cocco, Claudia
    Morandi, Fabio
    Prigione, Ignazia
    Pistoia, Vito
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (04) : 541 - 548
  • [5] Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer
    Arenberg, DA
    Keane, MP
    DiGiovine, B
    Kunkel, SL
    Morris, SB
    Xue, YY
    Burdick, MD
    Glass, MC
    Iannettoni, MD
    Strieter, RM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (03) : 465 - 472
  • [6] BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97
  • [7] The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes
    Balabanian, K
    Lagane, B
    Infantino, S
    Chow, KYC
    Harriague, J
    Moepps, B
    Arenzana-Seisdedos, F
    Thelen, M
    Bachelerie, F
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (42) : 35760 - 35766
  • [8] The significance of cancer cell expression of the chemokine receptor CXCR4
    Balkwill, F
    [J]. SEMINARS IN CANCER BIOLOGY, 2004, 14 (03) : 171 - 179
  • [9] Cancer and the chemokine network
    Balkwill, F
    [J]. NATURE REVIEWS CANCER, 2004, 4 (07) : 540 - 550
  • [10] Interaction of KAI1 on tumor cells with DARC on vascular endothelium leads to metastasis suppression
    Bandyopadhyay, Sucharita
    Zhan, Rui
    Chaudhuri, Asok
    Watabe, Misako
    Pai, Sudha K.
    Hirota, Shigeru
    Hosobe, Sadahiro
    Tsukada, Taisei
    Miura, Kunio
    Takano, Yukio
    Saito, Ken
    Pauza, Mary E.
    Hayashi, Sunao
    Wang, Ying
    Mohinta, Sonia
    Mashimo, Tomoyuki
    Iiizumi, Megumi
    Furuta, Eiji
    Watabe, Kounosuke
    [J]. NATURE MEDICINE, 2006, 12 (08) : 933 - 938